Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update

Go back to Rhythm Pharmaceuticals Reports Second Quarter 2022 Financial Results and Business Update
(NASDAQ: RYTM) Delayed: 101.50 +0.11 (0.11%)
Previous Close $101.39    52 Week High
Open $101.75    52 Week Low
Day High $102.89    P/E N/A 
Day Low $99.49    EPS
Volume 62,768